Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

K.A. Frerichs, M.C. Minnema, M.D. Levin, A. Broijl, G.M.J. Bos, M.J. Kersten, T. Mutis, C.P.M. Verkleij, I.S. Nijhof, P.W.C. Maas-Bosman, S.K. Klein, S. Zweegman, P. Sonneveld, N.W.C.J. van de Donk*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Keyphrases

INIS

Immunology and Microbiology